Could a Japanese Medicine Help Muscle Cramps in ALS?

Could a Japanese Medicine Help Muscle Cramps in ALS?
Credibility
Interest
Key Takeaway

A Japanese medicine called TJ-68 may help reduce muscle cramps for some patients with ALS, but more research is needed.

What They Found

Researchers studied a traditional Japanese medicine, TJ-68, to see if it could help with muscle cramps in people with ALS. Muscle cramps can be very uncomfortable and make daily activities harder, much like how a flat tire makes it difficult to drive. The study found that while TJ-68 didn't show clear benefits for everyone, it did help reduce the number of cramps for some participants. Additionally, people felt their overall condition improved after taking TJ-68. Importantly, the medicine was safe to use, with no serious side effects reported.

Who Should Care and Why

MS patients and caregivers should pay attention to these findings because muscle cramps can be a common challenge for many. Just like a good tool can make a job easier, finding effective treatments can improve daily life for those dealing with muscle issues. Caregivers can use this information to help support their loved ones in managing cramps. Even though TJ-68 isn't available in the USA yet, knowing that there are potential treatments out there can be hopeful. Healthcare providers might also consider this research when exploring options for muscle cramps in their patients.

Important Considerations

This study had some limitations, including a small number of participants, which means the results might not apply to everyone. It also didn't show a strong enough effect in the main measure, meaning we can't be sure TJ-68 will work for all ALS patients. More research with larger groups is needed to confirm these findings and understand how TJ-68 might be used in practice.

Article Topics:
ALSN‐of‐1 trialsTJ‐68 (Shakuyakukanzoto)muscle cramp scale (MCS)muscle cramps

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
New Tool Helps Understand Brain Changes in MS
New Tool Helps Understand Brain Changes in MS

12/1/2026

Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette

Read More
Quick Eye Scan Helps Tell Two Serious Optic Nerve Conditions Apart
Quick Eye Scan Helps Tell Two Serious Optic Nerve Conditions Apart

3/1/2026

Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea

Read More
Understanding Enterovirus Risks in MS Patients on Ocrelizumab
Understanding Enterovirus Risks in MS Patients on Ocrelizumab

3/1/2026

Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog

Read More
TREM2: Helping Brain Immune Cells Repair Nerves
TREM2: Helping Brain Immune Cells Repair Nerves

3/1/2026

Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo

Read More
New Hope for Women with MS: Boosting Anti-Inflammatory Response
New Hope for Women with MS: Boosting Anti-Inflammatory Response

3/1/2026

Discover how new research could help women with MS produce more IL-10, an important substance for co

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Muscle & nerve often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.